Nightfood Holdings Inc. (OTCQB: NGTF) announced that its subsidiary, TechForce Robotics, has successfully completed Phase 1 objectives under its joint development agreement with Oncotelic Therapeutics (OTCQB: OTLC), highlighted by the initial deployment of LIM-E, an autonomous laboratory support robot. The deployment marks TechForce’s first expansion into pharmaceutical and laboratory automation and validates the adaptability of its AI-enhanced robotics platform beyond hospitality and service-industry applications into life sciences and pharmaceutical environments.
TechForce said the deployment completed the initial operational goals established under the companies’ April 2026 collaboration agreement and will provide operational data and workflow insights to support future automation initiatives. The companies plan to continue evaluating opportunities in laboratory logistics, manufacturing support, AI-enhanced workflows and other automation applications, while Nightfood views healthcare, life sciences and pharmaceutical manufacturing as significant long-term growth markets for its Robotics-as-a-Service platform.
This milestone is significant because it demonstrates the cross-industry potential of TechForce's autonomous systems, which were originally developed for hospitality and foodservice settings. The successful deployment of LIM-E in a pharmaceutical laboratory suggests that the company's AI and robotics technology can be adapted to highly regulated environments, potentially opening up a large new market for Nightfood's Robotics-as-a-Service (RaaS) model. The implications for the pharmaceutical industry include improved efficiency, consistency, and scalability in laboratory workflows, which could accelerate research and development timelines.
For investors, this move signals Nightfood's diversification beyond its core hospitality focus into higher-margin, high-growth sectors. The collaboration with Oncotelic, a clinical-stage biopharmaceutical company focused on oncology and immunotherapy, provides a real-world testing ground for TechForce's technology. As the companies continue to evaluate opportunities in laboratory logistics and manufacturing support, the partnership could lead to broader adoption of robotics in pharmaceutical manufacturing, a sector that is increasingly looking to automation to address labor shortages and improve precision.
TechForce Robotics, a subsidiary of Nightfood Holdings, is an emerging robotics company focused on deploying AI-enhanced automation across multiple industries. The company develops, deploys, and scales autonomous robotic solutions for hospitality, foodservice, commercial, and now laboratory and pharmaceutical applications. TechForce operates through a vertically integrated platform combining proprietary robotics technology, real-world operating environments, and scalable manufacturing, and delivers its solutions through a RaaS model.
Nightfood Holdings, Inc. is focused on the development, integration, and deployment of AI-enhanced automation solutions across multiple commercial industries. Through its TechForce Robotics platform, the company develops and deploys autonomous robotic systems designed to improve operational efficiency, workflow consistency, and scalability across hospitality, foodservice, commercial, laboratory, and emerging enterprise automation environments.
For more information on the press release, visit https://ibn.fm/RFkfL. For the latest news and updates on Nightfood Holdings, visit http://ibn.fm/NGTF.
